A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-016-3735-x
Published Online: 2016-03-02
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhu, T.
Liu, C. L.
Zhang, Y. F.
Liu, Y. H.
Xu, F. P.
Zu, J.
Zhang, G. C.
Li, X. R.
Liao, N.
Wang, K.
Funding for this research was provided by:
the Science and Technology Planning Project of Guangdong Province, China (2012B031800405)
Text and Data Mining valid from 2016-02-01